INCB-54329

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameINCB-54329
Drug Alias NameINCB-54329INCB-054329
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 3 inhibitorsBromodomain-containing protein 2 inhibitorsBromodomain-containing protein 4 inhibitors
TargetsBromodomain-containing protein 3Bromodomain-containing protein 2Bromodomain-containing protein 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncyte Corp
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A